Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02393547 · ClinicalTrials.gov registry record · Phase 1
Lorcaserin for Preventing Weight Gain Among Smokers
A Phase 1 study of Tobacco Use Disorder and Weight Gain, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT02393547 is a Phase 1 study of Tobacco Use Disorder and Weight Gain that has completed, run by Mayo Clinic. The registered enrollment target is 20 participants, below the 239-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02393547, a Phase 1 study of Tobacco Use Disorder and Weight Gain, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be an open label clinical trial with all subjects receiving both lorcaserin and varenicline with a primary aim of reducing post cessation weight gain.
Conditions Studied
Interventions
- DRUG Varenicline
- DRUG Lorcaserin
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-09 |
| Est. Completion | 2015-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02393547
The ClinicalTrials.gov registry entry for NCT02393547 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 239-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (92% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Tobacco Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Varenicline is the first listed.
NCT02393547 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT02393547 about?
NCT02393547 is a clinical study titled "Lorcaserin for Preventing Weight Gain Among Smokers". This will be an open label clinical trial with all subjects receiving both lorcaserin and varenicline with a primary aim of reducing post cessation weight gain.
What is the current status of trial NCT02393547?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2013-09. Estimated completion is 2015-12.
What conditions does trial NCT02393547 study?
This clinical trial studies the following conditions: Tobacco Use Disorder, Weight Gain.
What interventions are being tested in trial NCT02393547?
The interventions under investigation include: Varenicline (DRUG), Lorcaserin (DRUG).
Who is sponsoring clinical trial NCT02393547?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02393547 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Oral Cannabidiol for Tobacco Cessation
RECRUITING · Phase 1
-
Persistence-Targeted Smoking Cessation
COMPLETED · Phase 1
-
Project 3, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in People With Current Affective Disorders
COMPLETED · Phase 1
-
Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3
COMPLETED · Phase 1
-
Brain Imaging in Tobacco Smokers During a Quit Attempt
COMPLETED · Phase 1
-
Project 2, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Opioid Abusers
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.